Evolus (EOLS) Receivables - Net (2019 - 2026)
Evolus' (EOLS) quarterly Receivables - Net came in at $52.2 million in Q1 2026, up 10.04% YoY from $47.5 million in Q1 2025, and down 4.53% on a QoQ basis from $54.7 million in Q4 2025.
Evolus (EOLS) Receivables - Net (2019 - 2026) Analysis & Trends
Evolus (EOLS) has 8 years of Receivables - Net data on file, last reported at $52.2 million in Q1 2026.
- Quarterly Receivables - Net rose 10.04% year-over-year to $52.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.2 million (up 10.04% YoY) and the FY2025 annual result came in at $54.7 million, up 14.71% from the prior year.
- Receivables - Net declined to $52.2 million in Q1 2026, from $54.7 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $54.7 million in Q4 2025 to a low of $16.8 million in Q1 2022.
- A 5-year average of $36.3 million and a median of $34.2 million in 2024 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2022 — Receivables - Net surged 114.94% — and 2026, when it increased 10.04%.
- Tracing EOLS's Receivables - Net over 5 years: stood at $22.4 million in 2022, then surged by 36.0% to $30.5 million in 2023, then soared by 56.19% to $47.7 million in 2024, then advanced by 14.71% to $54.7 million in 2025, then fell by 4.53% to $52.2 million in 2026.
- The last three Receivables - Net figures came in at $52.2 million (Q1 2026), $54.7 million (Q4 2025), and $50.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.49 Bn | 39.83 Bn | 2.15 Bn |
| 3 | Zoetis | 32.41 Bn | 30.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.01 Bn | 19.35 Bn | 683.80 Mn |
| 6 | Viatris | 18.94 Bn | 18.06 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.01 Bn | 11.48 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Evolus | 545.56 Mn | 500.39 Mn | 57.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.38 Mn |
| Jun 30, 2026 | 62.38 Mn |
| Mar 31, 2026 | 52.22 Mn |
| Mar 31, 2026 | 52.22 Mn |
| Dec 31, 2025 | 54.70 Mn |
| Dec 31, 2025 | 54.70 Mn |
| Sep 30, 2025 | 50.44 Mn |
| Sep 30, 2025 | 50.44 Mn |
| Jun 30, 2025 | 47.71 Mn |
| Jun 30, 2025 | 47.71 Mn |
| Mar 31, 2025 | 47.45 Mn |
| Mar 31, 2025 | 47.45 Mn |
| Dec 31, 2024 | 47.68 Mn |
| Dec 31, 2024 | 47.68 Mn |
| Sep 30, 2024 | 44.64 Mn |
| Sep 30, 2024 | 44.64 Mn |
| Jun 30, 2024 | 43.15 Mn |
| Jun 30, 2024 | 43.15 Mn |
| Mar 31, 2024 | 34.24 Mn |
| Mar 31, 2024 | 34.24 Mn |